The Key Differences between Human Papillomavirus-Positive and -Negative Head and Neck Cancers: Biological and Clinical Implications
Steven Francis Powell, Lexi Vu, William Charles Spanos et al. · Cancers · 2021
Head and neck squamous cell carcinoma (HNSCC) is a unique malignancy associated with two distinct risk factors: exposure to typical carcinogens and infection of human papillomavirus (HPV). HPV encodes the potent oncoproteins E6 and E7, which bypass many important oncogenic processes and result in cancer development. In contrast, HPV-negative HNSCC is developed through multiple mutations in diverse oncogenic driver genes. While the risk factors associated with HPV-positive and HPV-negative HNSCCs are discrete, HNSCC patients still show highly complex molecular signatures, immune infiltrations, and treatment responses even within the same anatomical subtypes. Here, we summarize the current understanding of biological mechanisms, treatment approaches, and clinical outcomes in comparison between HPV-positive and -negative HNSCCs.
Cited by 102 works. doi:10.3390/cancers13205206 Open-access PDF
Authors
References
- Cancer Statistics, 2021
- Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
- The NIH Human Microbiome Project
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
- The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial
- Comprehensive genomic characterization of head and neck squamous cell carcinomas
- microRNA Functions